Table 3.

Outcomes of 13 women with 22 pregnancies following recovery from TTP

WomanPregnancyPregnancy outcomeChild outcome
Normal Normal 
Normal Normal 
13 wk fetal loss NA 
12 wk fetal loss NA 
Normal Normal 
Normal Normal 
Severe preeclampsia Normal 
Severe preeclampsia Normal 
Normal Normal 
10 Normal Normal 
11 Preeclampsia Normal 
12 Preeclampsia, TTP relapse 29 d postpartum Normal 
13 Severe preeclampsia, TTP relapse 9 d postpartum Normal 
14 20 wk fetal loss NA 
15 Normal Normal 
16 Normal Normal 
17 Normal Normal 
10 18 SLE flare Normal 
11 19 Normal Normal 
20 Normal Normal 
12 21 Fetal growth retardation, delivery at 26 wk Died, sepsis 
13 22 Preeclampsia Normal 
WomanPregnancyPregnancy outcomeChild outcome
Normal Normal 
Normal Normal 
13 wk fetal loss NA 
12 wk fetal loss NA 
Normal Normal 
Normal Normal 
Severe preeclampsia Normal 
Severe preeclampsia Normal 
Normal Normal 
10 Normal Normal 
11 Preeclampsia Normal 
12 Preeclampsia, TTP relapse 29 d postpartum Normal 
13 Severe preeclampsia, TTP relapse 9 d postpartum Normal 
14 20 wk fetal loss NA 
15 Normal Normal 
16 Normal Normal 
17 Normal Normal 
10 18 SLE flare Normal 
11 19 Normal Normal 
20 Normal Normal 
12 21 Fetal growth retardation, delivery at 26 wk Died, sepsis 
13 22 Preeclampsia Normal 

Sixteen pregnancies in women 1 through 10 were previously reported.27  Women 5 and 8 have had an additional normal pregnancy since this previous publication. No women received prophylactic treatments for TTP (eg, rituximab) preceding or during their pregnancies. Women 1, 3, 9, and 13 each had 1 previous pregnancy that was associated with their initial episode of TTP, occurring at 7 weeks’ gestation, the day of delivery, postpartum day 9 and postpartum day 45. Only woman 9 has had relapse episodes of TTP following these pregnancies; she had 2 relapses (not associated with a pregnancy) 25 and 35 months following her normal pregnancy. Woman 12 is currently pregnant, due in September 2018.

NA, child outcome when fetal loss occurred before the gestational age of viability.

Close Modal

or Create an Account

Close Modal
Close Modal